Domanskyi A - Search Results

1

Genetic mutations linked to Parkinson's disease differentially control nucleolar activity in pre-symptomatic mouse models.

Evsyukov V, Domanskyi A, Bierhoff H, Gispert S, Mustafa R, Schlaudraff F, Liss B, Parlato R. Evsyukov V, et al. Among authors: domanskyi a. Dis Model Mech. 2017 May 1;10(5):633-643. doi: 10.1242/dmm.028092. Epub 2017 Mar 30. Dis Model Mech. 2017. PMID: 28360124 Free PMC article.

2

Nucleolar disruption in dopaminergic neurons leads to oxidative damage and parkinsonism through repression of mammalian target of rapamycin signaling.

Rieker C, Engblom D, Kreiner G, Domanskyi A, Schober A, Stotz S, Neumann M, Yuan X, Grummt I, Schütz G, Parlato R. Rieker C, et al. Among authors: domanskyi a. J Neurosci. 2011 Jan 12;31(2):453-60. doi: 10.1523/JNEUROSCI.0590-10.2011. J Neurosci. 2011. PMID: 21228155 Free PMC article.

3

Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models.

Domanskyi A, Geissler C, Vinnikov IA, Alter H, Schober A, Vogt MA, Gass P, Parlato R, Schütz G. Domanskyi A, et al. FASEB J. 2011 Sep;25(9):2898-910. doi: 10.1096/fj.11-181958. Epub 2011 May 18. FASEB J. 2011. PMID: 21593433

4

Oxidative Stress in Neurodegenerative Diseases.

Domanskyi A, Parlato R. Domanskyi A, et al. Antioxidants (Basel). 2022 Mar 5;11(3):504. doi: 10.3390/antiox11030504. Antioxidants (Basel). 2022. PMID: 35326154 Free PMC article.

5

Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene Therapy.

Domanskyi A, Saarma M, Airavaara M. Domanskyi A, et al. Hum Gene Ther. 2015 Aug;26(8):550-9. doi: 10.1089/hum.2015.065. Hum Gene Ther. 2015. PMID: 26176331 Review.

6

Back and to the Future: From Neurotoxin-Induced to Human Parkinson's Disease Models.

Airavaara M, Parkkinen I, Konovalova J, Albert K, Chmielarz P, Domanskyi A. Airavaara M, et al. Among authors: domanskyi a. Curr Protoc Neurosci. 2020 Mar;91(1):e88. doi: 10.1002/cpns.88. Curr Protoc Neurosci. 2020. PMID: 32049438 Review.

7

Downregulation of tyrosine hydroxylase phenotype after AAV injection above substantia nigra: Caution in experimental models of Parkinson's disease.

Albert K, Voutilainen MH, Domanskyi A, Piepponen TP, Ahola S, Tuominen RK, Richie C, Harvey BK, Airavaara M. Albert K, et al. Among authors: domanskyi a. J Neurosci Res. 2019 Mar;97(3):346-361. doi: 10.1002/jnr.24363. Epub 2018 Dec 12. J Neurosci Res. 2019. PMID: 30548446

8

Dicer and microRNAs protect adult dopamine neurons.

Chmielarz P, Konovalova J, Najam SS, Alter H, Piepponen TP, Erfle H, Sonntag KC, Schütz G, Vinnikov IA, Domanskyi A. Chmielarz P, et al. Among authors: domanskyi a. Cell Death Dis. 2017 May 25;8(5):e2813. doi: 10.1038/cddis.2017.214. Cell Death Dis. 2017. PMID: 28542144 Free PMC article.

9

Detecting Oxidative Stress Biomarkers in Neurodegenerative Disease Models and Patients.

Sidorova Y, Domanskyi A. Sidorova Y, et al. Among authors: domanskyi a. Methods Protoc. 2020 Sep 24;3(4):66. doi: 10.3390/mps3040066. Methods Protoc. 2020. PMID: 32987935 Free PMC article.

10

Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.

Konovalova J, Gerasymchuk D, Parkkinen I, Chmielarz P, Domanskyi A. Konovalova J, et al. Among authors: domanskyi a. Int J Mol Sci. 2019 Nov 30;20(23):6055. doi: 10.3390/ijms20236055. Int J Mol Sci. 2019. PMID: 31801298 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters